ResearcherJiangsu Province HospitalNo recent work listed
Hao Gao Gao
Matched on ORCID iD 0000-0003-1178-0121; OpenAlex author ID A5091107099. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 5
- Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. Co-author DOI 10.1002/cam4.5472↗
- Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Co-author DOI 10.1001/jamanetworkopen.2021.48721↗
- Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. Co-author DOI 10.3389/fcell.2021.714718↗
- Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. First author DOI 10.1002/cam4.3559↗
- Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. Co-author DOI 10.1007/s00423-019-01766-1↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yi Miao · 5 shared papers, 2019–2023 · strength 0.66
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Guangfu Wang · 4 shared papers, 2019–2023 · strength 0.54
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Zipeng Lu · 3 shared papers, 2021–2023 · strength 0.45
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Paper Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. DOI 10.1001/jamanetworkopen.2021.48721↗
- Lingdi Yin · 3 shared papers, 2019–2022 · strength 0.34
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Paper Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. DOI 10.1001/jamanetworkopen.2021.48721↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Junli Wu · 3 shared papers, 2019–2022 · strength 0.34
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Paper Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. DOI 10.1001/jamanetworkopen.2021.48721↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Kuirong Jiang · 3 shared papers, 2019–2022 · strength 0.34
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Paper Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. DOI 10.1001/jamanetworkopen.2021.48721↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Kai Zhang · 2 shared papers, 2020–2023 · strength 0.32
- Kai Zhang · 2 shared papers, 2019–2022 · strength 0.21
- Wentao Gao · 2 shared papers, 2019–2022 · strength 0.21
- Jishu Wei · 2 shared papers, 2019–2022 · strength 0.21
- Baobao Cai · 1 shared paper, 2023 · strength 0.19
- Kuirong Jiang · 1 shared paper, 2023 · strength 0.19
- Xumin Huang · 1 shared paper, 2021 · strength 0.13
- Shangnan Dai · 1 shared paper, 2021 · strength 0.13
- Weizhong Yuan · 1 shared paper, 2020 · strength 0.13
- Qiang Li · 1 shared paper, 2022 · strength 0.13
- Jian‐Min Chen · 1 shared paper, 2022 · strength 0.13
- Chunhua Xi · 1 shared paper, 2022 · strength 0.13
- Jun Yu · 1 shared paper, 2022 · strength 0.13
- Min Tu · 1 shared paper, 2022 · strength 0.13
- Nan Lyu · 1 shared paper, 2019 · strength 0.08
- Yunpeng Peng · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.